A Synergistic Anticancer FAK and HDAC Inhibitor Combination Discovered by a Novel Chemical–Genetic High-Content Phenotypic Screen
John C. Dawson(Edinburgh Cancer Research), Margaret C. Frame(Edinburgh Cancer Research)
Cited by 22
Related Papers
Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity
|Cell|2015|414
Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks
|eLife|2017|39
Epidermal Growth Factor Receptor substrate 8 (Eps8) controls Src/FAK-dependent phenotypes in squamous carcinoma cells
|Journal of Cell Science|2014|24
FAK regulates IL-33 expression by controlling chromatin accessibility at c-Jun motifs
|Scientific Reports|2021|23
The autophagy protein Ambra1 regulates gene expression by supporting novel transcriptional complexes
|Journal of Biological Chemistry|2020|20